ArticleDermatology and therapy2023

Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical Study.

Christopher John Wynne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.